Molecular Interaction Maps and Analysis of Bioregulatory Networks

分子相互作用图谱和生物调节网络分析

基本信息

  • 批准号:
    8552733
  • 负责人:
  • 金额:
    $ 13.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

This project is performed in close collaboration with Dr. Kohn?s group in LMP and consists of two lines of study. First, we have recently developed and released several tools for creating and editing MIM diagrams (Luna, Karac et al. 2011; Luna, Sunshine et al. 2011; Chandan et al., 2012). These tools should make it easier for developers to build MIM-related software, users to create and edit MIM diagrams, and also, help bridge differences between features found in MIM and related notations, such as the BioPAX exchange standard (Demir et al., 2010) and the systems biology graphical notation (SBGN) that is developed by an international consortium with our participation (Le Novere, Hucka et al. 2009; van Iersel et al., 2012). We use MIMs as a basis for mathematical modeling of cellular regulatory networks in an effort to shed light on basic feedback mechanisms that modulate cell proliferation. The first network we have investigated describes the regulation of tumor suppressor p53 by Mdm2 and MdmX in response to DNA damage (Kim, Aladjem et al. 2010). The simplified network model was derived from a detailed molecular interaction map (MIM) that exhibited four coherent DNA damage response pathways. The results suggest that MdmX may amplify or stabilize DNA damage-induced p53 responses via non-enzymatic interactions. These studies led us to suggest a possible role of MdmX in the response of p53 to DNA damage. This model is currently under experimental investigation using a system in which the transcriptional activity of p5 can be directly visualized. In a separate line of study we have created an extended computational model of a mammalian circadian clock that emphasizes the roles of chromatin remodeling and metabolic pathways on the regulation of circadian rhythms. This model incorporates recent experimental evidence suggesting a role for the nicotinamide adenine dinucleotide (NAD+)-dependent histone deacetylase SIRT1 in regulating circadian rhythms. Simulation studies using the molecular interaction network included in the model were able to recapitulate circadian behavior. Development and analysis of this model will provide insights into the regulation of circadian rhythms and the potential role of SIRT1 in cancer biology. In the future we aim to combine these studies with experimental characterization of cell cycle regulatory networks that modulate DNA synthesis and affect cell growth. Results from these studies may also add to knowledge on the role of circadian rhythms on the toxicity and activity of therapeutics, including common cancer drugs.
该项目是在与科恩博士密切合作进行?的LMP组,包括两个研究线。 首先,我们最近开发并发布了几种用于创建和编辑MIM图的工具(Luna,Karac等人,2011年; Luna,Sunshine等人,2011年; Chandan等人,2012年)。这些工具应该使开发人员更容易构建MIM相关软件,用户更容易创建和编辑MIM图,并且还有助于弥合MIM中发现的特征与相关符号之间的差异,例如BioPAX交换标准(Demir等人,2010)和由我们参与的国际联盟开发的系统生物学图形符号(SBGN)(Le Novere,Hucka等人,2009;货车Iersel等人,2012年)。我们使用MIMs作为细胞调控网络的数学建模的基础,努力阐明调节细胞增殖的基本反馈机制。我们研究的第一个网络描述了Mdm 2和MdmX对肿瘤抑制因子p53的调节,以响应DNA损伤(Kim,Aladjem et al. 2010)。简化的网络模型是从一个详细的分子相互作用图(MIM),表现出四个连贯的DNA损伤反应途径。结果表明,MdmX可以通过非酶相互作用放大或稳定DNA损伤诱导的p53反应。这些研究使我们提出了MdmX在p53对DNA损伤的反应中的可能作用。 该模型目前正在实验研究中,使用的系统中,p5的转录活性可以直接可视化。在另一项研究中,我们建立了一个哺乳动物生物钟的扩展计算模型,强调染色质重塑和代谢途径对昼夜节律调节的作用。该模型结合了最近的实验证据,表明烟酰胺腺嘌呤二核苷酸(NAD+)依赖性组蛋白脱乙酰酶SIRT 1在调节昼夜节律中的作用。使用模型中包含的分子相互作用网络的模拟研究能够概括昼夜节律行为。该模型的开发和分析将为昼夜节律的调节和SIRT 1在癌症生物学中的潜在作用提供见解。在未来,我们的目标是联合收割机这些研究与细胞周期调控网络,调节DNA合成和影响细胞生长的实验表征。这些研究的结果也可能增加关于昼夜节律对治疗药物(包括常见癌症药物)的毒性和活性的作用的知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

mirit aladjem其他文献

mirit aladjem的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('mirit aladjem', 18)}}的其他基金

Initiation of DNA Replication in Mammalian Cells
哺乳动物细胞中 DNA 复制的启动
  • 批准号:
    8552687
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Initiation of DNA Replication in Mammalian Cells
哺乳动物细胞中 DNA 复制的启动
  • 批准号:
    8348998
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Initiation of DNA Replication in Mammalian Cells
哺乳动物细胞中 DNA 复制的启动
  • 批准号:
    10926012
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Molecular Interaction Maps and Analysis of Bioregulatory Networks
分子相互作用图谱和生物调节网络分析
  • 批准号:
    7733086
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Initiation of DNA Replication in Mammalian Cells
哺乳动物细胞中 DNA 复制的启动
  • 批准号:
    10014364
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Molecular Interaction Maps and Analysis of Bioregulatory
分子相互作用图谱和生物调节分析
  • 批准号:
    7338658
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Molecular Interaction Maps and Analysis of Bioregulatory Networks
分子相互作用图谱和生物调节网络分析
  • 批准号:
    8763137
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Molecular Interaction Maps and Analysis of Bioregulatory Networks
分子相互作用图谱和生物调节网络分析
  • 批准号:
    8937770
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Initiation of DNA Replication in Mammalian Cells
哺乳动物细胞中 DNA 复制的启动
  • 批准号:
    8937729
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:
Initiation of DNA Replication in Mammalian Cells
哺乳动物细胞中 DNA 复制的启动
  • 批准号:
    7965300
  • 财政年份:
  • 资助金额:
    $ 13.05万
  • 项目类别:

相似海外基金

Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
  • 批准号:
    9975367
  • 财政年份:
    2020
  • 资助金额:
    $ 13.05万
  • 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
  • 批准号:
    16K11932
  • 财政年份:
    2016
  • 资助金额:
    $ 13.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
  • 批准号:
    19591274
  • 财政年份:
    2007
  • 资助金额:
    $ 13.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
  • 批准号:
    6346309
  • 财政年份:
    2000
  • 资助金额:
    $ 13.05万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    2720213
  • 财政年份:
    1999
  • 资助金额:
    $ 13.05万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    6513197
  • 财政年份:
    1999
  • 资助金额:
    $ 13.05万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    7101017
  • 财政年份:
    1999
  • 资助金额:
    $ 13.05万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    6894842
  • 财政年份:
    1999
  • 资助金额:
    $ 13.05万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    2885074
  • 财政年份:
    1999
  • 资助金额:
    $ 13.05万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    6174221
  • 财政年份:
    1999
  • 资助金额:
    $ 13.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了